Kyntra Bio (KYNB) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Kyntra Bio (KYNB) over the last 12 years, with Q3 2025 value amounting to -$118.9 million.
- Kyntra Bio's Enterprise Value fell 859.0% to -$118.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$118.9 million, marking a year-over-year decrease of 859.0%. This contributed to the annual value of -$35.0 million for FY2024, which is 8366.7% up from last year.
- As of Q3 2025, Kyntra Bio's Enterprise Value stood at -$118.9 million, which was down 859.0% from -$6.4 million recorded in Q2 2025.
- In the past 5 years, Kyntra Bio's Enterprise Value ranged from a high of -$6.4 million in Q2 2025 and a low of -$525.0 million during Q1 2021
- Over the past 5 years, Kyntra Bio's median Enterprise Value value was -$314.2 million (recorded in 2023), while the average stood at -$272.7 million.
- Its Enterprise Value has fluctuated over the past 5 years, first plummeted by 954.9% in 2022, then surged by 9548.49% in 2025.
- Over the past 5 years, Kyntra Bio's Enterprise Value (Quarter) stood at -$385.2 million in 2021, then dropped by 9.55% to -$422.0 million in 2022, then skyrocketed by 49.26% to -$214.1 million in 2023, then skyrocketed by 83.67% to -$35.0 million in 2024, then tumbled by 240.09% to -$118.9 million in 2025.
- Its Enterprise Value was -$118.9 million in Q3 2025, compared to -$6.4 million in Q2 2025 and -$18.6 million in Q1 2025.